A Single Arm, Open Label, Multicenter, Phase II Study of Famitinib in Patients With Gastrointestinal Stromal Tumor
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Famitinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
- 19 Apr 2018 Last checked against ClinicalTrials.gov record.
- 16 Apr 2018 Planned End Date changed from 1 Jun 2016 to 1 Jun 2019.
- 16 Apr 2018 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2018.